Insider · CIK 0001647141
Michael E. Faerm
Files at VIRX (Viracta Therapeutics, Inc.), ATAI (AtaiBeckley Inc.). First filing -, latest -.
In brief
Michael E. Faerm files SEC Form 4 as CFO at VIRX (Viracta Therapeutics, Inc.), and also at ATAI (AtaiBeckley Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael E. Faerm has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Stock Optionderivative | -1,275,000 | - | - | 0 | 34 d ago |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -285,000 | - | - | 0 | 34 d ago |
| Mar 11, 2026 | ATAI AtaiBeckley Inc. | AGrant or award Stock Optionderivative | +1,275,000 | $0.00 | $0 | 1,275,000 | Mar 13, 2026 |
| Mar 11, 2026 | ATAI AtaiBeckley Inc. | AGrant or award Restricted Stock Unitsderivative | +285,000 | $0.00 | $0 | 285,000 | Mar 13, 2026 |
| May 14, 2024 | VIRX Viracta Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | May 16, 2024 |
Questions about Michael E. Faerm
Answered from the filings on this page, as of the latest one.
Is Michael E. Faerm buying or selling?
Michael E. Faerm has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael E. Faerm's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael E. Faerm has 0.
Where does Michael E. Faerm file Form 4?
Michael E. Faerm has filed Form 4 at VIRX (Viracta Therapeutics, Inc.) as Chief Financial Officer; ATAI (AtaiBeckley Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.